ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

ClinicalTrials.gov ID: NCT03525613

Public ClinicalTrials.gov record NCT03525613. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal Pegcetacoplan Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Study identification

NCT ID
NCT03525613
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Apellis Pharmaceuticals, Inc.
Industry
Enrollment
637 participants

Conditions and interventions

Interventions

  • APL-2 Drug
  • Sham Procedure Other

Drug · Other

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 30, 2018
Primary completion
Jun 27, 2021
Completion
Jun 27, 2022
Last update posted
Jul 5, 2023

2018 – 2022

United States locations

U.S. sites
67
U.S. states
27
U.S. cities
59
Facility City State ZIP Site status
Arizona Retina & Vitreous Consultants Phoenix Arizona 85021
California Retina Consultants Bakersfield California 93309
Retina Vitreous Associates Medical Group Beverly Hills California 90211
Retinal Diagnostic Center Campbell California 95508
Retina Consultants of Orange County Fullerton California 92835
Atlantis Eyecare Huntington Beach California 92647
University of California, San Diego, Jacobs Retina La Jolla California 92093
Byers Eye Institute at Stanford, Stanford School of Medicine Palo Alto California 94303
Doheny Eye Center UCLA Pasadena California 91105
Retina Consultants San Diego Poway California 92064
Retinal Consultants Med Group, Inc. Sacramento California 95819
Orange County Retina Medical Group Santa Ana California 92705
California Retina Consultants Santa Barbara California 93103
Southwest Retina Research Center, LLC Durango Colorado 81301
Colorado Retina Associates Golden Colorado 80401
Retina Group of New England Waterford Connecticut 06385
Blue Ocean Clinical Research / The Macula Center Clearwater Florida 33761
National Ophthalmic Research Institute (Retina Consultants of Southwest Florida) Fort Myers Florida 33912
Bascom Palmer Eye Institute Miami Florida 33136
Bascom Palmer Eye Institute of Naples Naples Florida 34103
Retina Specialty Institute Pensacola Florida 32503
Center for Retina and Macular Disease Winter Haven Florida 33880
Southeast Retina Center, PC Augusta Georgia 30909
Gailey Eye Clinic Retina Center Bloomington Illinois 61704
Northwestern Feinberg School of Medicine Chicago Illinois 60611
Rush University Medical Center Chicago Illinois 60612
Midwest Eye Institute Indianapolis Indiana 46290
Retina and Vitreous Associates of Kentucky, PSC dba Retina Associates of Kentucky Lexington Kentucky 40509
Retina Associates New Orleans Metairie Louisiana 70006
The Retina Care Center Baltimore Maryland 21209
The Retina Group of Washington Chevy Chase Maryland 20815
Cumberland Valley Retina Center Hagerstown Maryland 21740
Mid Atlantic Retina Specialists Hagerstown Maryland 21740
Tufts Medical Center Boston Massachusetts 02116
New England Retina Consultants Springfield Massachusetts 01107
Michigan Medicine Kellogg Eye Center Ann Arbor Michigan 48105
Associated Retinal Consultants, P.C Grand Rapids Michigan 49564
VitreoRetinal Surgery PA Minneapolis Minnesota 55435
Sierra Eye Associates Reno Nevada 89502
Retina Center of NJ, LLC Bloomfield New Jersey 07003
NJ Retina Toms River New Jersey 08755
Vision Research Center Eye Associates of NM Albuquerque New Mexico 87109
Ophthalmic Consultants of Long Island Lynbrook New York 11563
New York Eye and Ear Infirmary of Mount Sinai New York New York 10003
Vitreous Retina Macula Consultants of NY New York New York 10022
Duke University, Duke Eye Center Durham North Carolina 27710
Research - Retina Vitreous Center Edmond Oklahoma 73013
Oregon Retina, LLP Eugene Oregon 97405
Mid Atlantic Retina Bethlehem Pennsylvania 18017
Retina Vitreous Consultants Monroeville Pennsylvania 15146
Mid Atlantic Retina, Wills Eye Hospital Philadelphia Pennsylvania 19107
AIO Visionary Eye Care West Mifflin Pennsylvania 15122
Charles Retina Institute Germantown Tennessee 38138
Tennessee Retina, PC Nashville Tennessee 37203
Retina Research Institute of Texas Abilene Texas 79606
Texas Retina Associates Dallas Texas 75231
Houston Eye Associates Houston Texas 77025
Retina Consultants of Houston, PA Houston Texas 77030
San Antonia Eye Center San Antonio Texas 78215
Medical Center Ophthalmology Associates San Antonio Texas 78240
Retina Associates of South Texas San Antonio Texas 78240
Retinal Consultants of San Antonio San Antonio Texas 78240
Brown Retina Institute San Antonio Texas 78251
Strategic Clinical Research Group Willow Park Texas 76087
University of Utah - John A. Moran Center Salt Lake City Utah 84132
Emerson Clinical Research Institute Falls Church Virginia 22046
University of Wisconsin Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03525613, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2023 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03525613 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →